1. Home
  2. ENVX vs CSTL Comparison

ENVX vs CSTL Comparison

Compare ENVX & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$3.06

Market Cap

741.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$34.85

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVX
CSTL
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
741.7M
722.8M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
ENVX
CSTL
Price
$3.06
$34.85
Analyst Decision
Buy
Strong Buy
Analyst Count
9
6
Target Price
$13.61
$45.50
AVG Volume (30 Days)
5.2M
279.0K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
40.94
N/A
EPS
N/A
N/A
Revenue
$31,821,000.00
$344,229,000.00
Revenue This Year
$30.37
$2.42
Revenue Next Year
$238.73
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
37.91
3.66
52 Week Low
$2.85
$17.72
52 Week High
$14.21
$44.28

Technical Indicators

Market Signals
Indicator
ENVX
CSTL
Relative Strength Index (RSI) 33.45 59.22
Support Level N/A $22.88
Resistance Level $3.55 $42.03
Average True Range (ATR) 0.15 1.42
MACD 0.02 -0.03
Stochastic Oscillator 15.00 61.55

Price Performance

Historical Comparison
ENVX
CSTL

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: